Persistence to COPD therapies and impact on exacerbations: a French claims data study
F. Dalon (Lyon, France), G. Devouassoux (Lyon, France), M. Belhassen (Lyon, France), G. Nachbaur (Rueil-Malmaison, France), C. Correia Da Silva (Rueil-Malmaison, France), L. Sail (Rueil-Malmaison, France), C. Chouaid (Créteil, France), E. Van Ganse (Lyon, France)
Source: International Congress 2018 – Respiratory epidemiology: from COPD to factors that associate with lung function and infections
Disease area: Airway diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
F. Dalon (Lyon, France), G. Devouassoux (Lyon, France), M. Belhassen (Lyon, France), G. Nachbaur (Rueil-Malmaison, France), C. Correia Da Silva (Rueil-Malmaison, France), L. Sail (Rueil-Malmaison, France), C. Chouaid (Créteil, France), E. Van Ganse (Lyon, France). Persistence to COPD therapies and impact on exacerbations: a French claims data study. 2273
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: